UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000044818
Receipt No. R000051184
Scientific Title PREP-MD study: PRedictors of functional Recovery in Patients with Mood Disorder
Date of disclosure of the study information 2021/07/20
Last modified on 2021/07/09 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Research on Predictors of Recovery in Mood Disorders
Acronym PREP-MD study
Scientific Title PREP-MD study: PRedictors of functional Recovery in Patients with Mood Disorder
Scientific Title:Acronym PREP-MD study
Region
Japan

Condition
Condition Major Depressive Disorder, Bipolar disorder
Classification by specialty
Psychiatry
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is to identify predictors of functional recovery in mood disorders.
Basic objectives2 Others
Basic objectives -Others In recent years, the number of mental health problems among workers has been on the rise, and the issues of absence from work and return to work associated with mental illness have been greatly highlighted. Mood disorders, mainly major depressive disorder and bipolar disorder, are mental disorders characterized by depressed mood and decreased interest and pleasure. The outcomes of mood disorders are known to vary among individuals, but the psychological, social, and biological factors that determine them are not clear. The purpose of this study is to explore the psychological, social, and biological factors that predict social recovery from mood disorders.
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Psychological, social, and biological factors predicting functional recovery in mood disorders
Key secondary outcomes Differences in social adjustment between the "recovery" and "non-recovery" groups on the Japanese version of the Self-Administered Social Adjustment Scale (SASS).
Differences between the "recovery" and "non-recovery" groups in physician-administered objective depression ratings (HAM-D) and subjective depression ratings (BDI-II).
Comparison of job titles between the "recovery" and "non-recovery" groups.
Differences in social networks using the LSNS-6 between the "recovery" and "non-recovery" groups
Differences in developmental disability-related scales (AQ-J, ASRS) between the "recovery" and "non-recovered" groups.
Differences between the "recovery" and "non-recovered" groups on the UCLA Loneliness Scale (loneliness)
Differences in self-esteem between the "recovery" and "non-recovery" groups.
Differences in self-esteem between the "recovery" and "non-recovery" groups on the Lazarus Stress Coping Inventory of stress coping behaviors.
Differences in the Mood and Fatigue Checklist between the "recovery" and "non-recovery" groups.
Differences between the "recovery" and "non-recovery" groups in attention and memory using the THINC-it tablet cognitive function test.
Difference in imipramine equivalents of antidepressants between the "recovery" and "non-recovery" groups
Difference in diazepam equivalents of benzodiazepines between the "recovery" and "non-recovery" groups.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >=
Gender Male and Female
Key inclusion criteria Patients undergoing outpatient treatment at the Department of Neuropsychiatry, The Jikei University School of Medicine or the Katsushika Medical Center, The Jikei University School of Medicine.
Patients with a DSM-5 diagnosis of major depressive disorder or bipolar affective disorder
Patients who have achieved functional recovery (defined as those who have a score of 7 or less on the 17-point version of the Hamilton Depression Rating Scale and have been working for at least 6 months at the time of the survey), or those who have not yet achieved functional recovery (those who do not meet the aforementioned criteria for functional recovery).
Patients who are able to read and understand the notice regarding consent explanation.
Key exclusion criteria Patients with psychiatric symptoms such as depressed mood, anxiety, agitation, elated mood, aggression, etc., who have poor judgment and have difficulty in participating in the study voluntarily.
Patients who are found to be in a manic or hypomanic state by the attending physician or physician in charge.
Patients who have been diagnosed with intellectual disability, substance-related disorder, or organic mental disorder.
Patients who are judged as inappropriate by the attending physician or the physician in charge.
Target sample size 240

Research contact person
Name of lead principal investigator
1st name Junpei
Middle name
Last name Ishii
Organization Jikei University School of Medicine
Division name Department of Psychiatry
Zip code 105-8461
Address 3-25-8 Nishi-shinbashi, Minato-ku, Japan
TEL 03-3433-1111
Email jishii@jikei.ac.jp

Public contact
Name of contact person
1st name Junpei
Middle name
Last name Ishii
Organization Jikei University School of Medicine
Division name Department of Psychiatry
Zip code 105-8461
Address 3-25-8 Nishi-shinbashi, Minato-ku, Japan
TEL 03-3433-1111
Homepage URL
Email jishii@jikei.ac.jp

Sponsor
Institute Jikei University School of Medicine
Department of Psychiatry
Institute
Department

Funding Source
Organization Jikei University School of Medicine
Department of Psychiatry
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ethics Committee of Jikei University School of Medicine
Address 3-25-8 Nishi-shinbashi, Minato-ku, Japan
Tel 03-3433-1111
Email crb@jikei.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京慈恵会医科大学附属病院

Other administrative information
Date of disclosure of the study information
2021 Year 07 Month 20 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2021 Year 06 Month 21 Day
Date of IRB
2021 Year 06 Month 21 Day
Anticipated trial start date
2021 Year 06 Month 21 Day
Last follow-up date
2023 Year 01 Month 31 Day
Date of closure to data entry
2023 Year 04 Month 30 Day
Date trial data considered complete
2023 Year 04 Month 30 Day
Date analysis concluded
2023 Year 04 Month 30 Day

Other
Other related information NA

Management information
Registered date
2021 Year 07 Month 09 Day
Last modified on
2021 Year 07 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051184